Replay available

Aquestive Therapeutics, Inc. (AQST) Q2 2025 Earnings Call

Aquestive Therapeutics, Inc. (NASDAQ: AQST) Q2 2025 earnings conference call, held 2025-08-12. Replay captured from the company's public earnings webcast.

Tue, August 12, 2025 at 8:00 AMendedReplay
Aquestive Therapeutics, Inc. (AQST) Q2 2025 Earnings Call

Hosted by

Featured presenters

Ryan Korb

Host

Dan Barber

Chief Executive Officer

Ernie Toth

Chief Financial Officer

Dr. Carl Krause

Chief Medical Officer

Sherry Korchinski

Chief Commercial Officer

David M. Salem

Analyst, Piper Sandler

Kristin Klitschko

Analyst, Cancer, Prince Gerald

Andreas Agreitz

Analyst, Oppenheimer

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Aquestive Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.698 Good day and thank you for standing by. Welcome to the Request of Therapeutics second 00:00:04.698 -- 00:00:10.105 quarter 2025 earnings conference call. At this time, all participants are in listen-only 00:00:10.105 -- 00:00:14.191 mode. After the speaker's presentation, there will be a question and answer session. 00:00:14.191 -- 00:00:19.018 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:19.018 -- 00:00:22.102 You will then hear an automated message advising your hand is raised. 00:00:22.102 -- 00:00:24.606 To withdraw your question, please press star 1-1 again. 00:00:24.606 -- 00:00:27.858 Please be advised that today's conference is pre-recorded. 00:00:27.858 -- 00:00:31.381 I would like to hand the conference over to our first speaker today, Ryan Korb. 00:00:31.381 -- 00:00:33.762 Please go ahead. 00:00:34.684 -- 00:00:38.288 Thank you, operator. Good morning, and welcome to today's call. 00:00:38.288 -- 00:00:43.052 On today's call, I'm joined by Dan Barber, Chief Executive Officer, and Ernie Toth, Chief 00:00:43.052 -- 00:00:46.896 Financial Officer, who are going to provide an overview of recent business developments 00:00:46.896 -- 00:00:51.420 and performance for the second quarter of 2025, followed by a Q&A session. 00:00:51.420 -- 00:00:53.702 During the Q&A session, the team will be joined by Dr. 00:00:53.702 -- 00:00:58.703 Carl Krause, Chief Medical Officer, and Sherry Korchinski, Chief Commercial Officer. 00:00:58.703 -- 00:01:02.090 As a reminder, the company's remarks today correspond with the earnings release that 00:01:02.090 -- 00:01:06.357 was issued after market closed yesterday. In addition, a recording of today's call will 00:01:06.357 -- 00:01:09.804 be made...